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Abstract: It has been recognized that Gastrodia elata Bl (GE), an oriental herb medicine, ameliorates various neurologi-
cal disorders, that GE modulates the monoaminergic and GABAergic systems, and that GE possess antioxidant activities. 
We examined whether GE affects methamphetamine (MA)-induced striatal dopaminergic toxicity in mice. Treatment  
with MA (7.5 mg/kg, i.p.  4) resulted in significant decreases in behavioural activity (as shown by locomotor activity  
and rota rod performance), dopamine level, tyrosine hydroxylase (TH) activity, and TH protein expression (as evaluated 
by immunocytochemistry and western blot analysis). In addition, MA treatment showed significant increases in lipid  
peroxidation [as evaluated by 4-hydroxy-2-nonenal (4-HNE) expression and malondialdehyde formation], protein   
oxidation (as shown by protein carbonyl expression and its formation), and reactive oxygen species (ROS) formation. 
Treatment with GE significantly attenuates MA-induced behavioural and dopaminergic impairments, and oxidative 
stresses in a dose-dependent manner. Our results suggest that GE treatment shows anti-dopaminergic effects in response 
to MA insult via, at least in part, inhibiting oxidative stresses in the striatum of the mice.  
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INTRODUCTION 
 Gastrodia  elata Bl (GE) is a well-known herb agent that 
has been used to treat headache, paralysis, migraine, and 
other neurological disorders in oriental countries for centu-
ries [1]. Prolonged GE treatment significantly increased do-
pamine (DA) concentration and decreased DA turnover in 
the striatum of the rats, suggesting that GE modulates DA 
system in the rats [2]. Recently, we filed a patent (Korean 
PCT10-2010-0000818; “pharmaceutical compositions con-
taining GE extract useful for Parkinson’s disease”) to extend 
neuropharmacological indication of GE. 
  Earlier evidences suggest that GE exerts antioxidant   
activities, which are attributable to its components (i.e.   
hydroxybenzyl aclcohol, vanillyl alcohol, vanillin and   
hydroxybenzaldehyde), and that their antioxidant effect   
in vitro is more potent than that by melatonin [3]. 
  Methamphetamine (MA) leads to long-lasting depletion 
of nigrostriatal DA [4, 5], which is associated with increased 
oxidative damage [4, 6-9]. It has been suggested that humans  
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who abuse MA have an increased risk for the PD later in life 
[6, 10]. Thus, MA-induced dopaminergic toxicity has been 
considered to be one of the important models for PD [5, 11, 
12]. 
  The present study was designed to investigate the phar-
macological activity of GE on dopaminergic neurons to MA 
toxicity in mice. We evaluated the effects of GE on the   
dopaminergic impairments and oxidative stresses [i.e., lipid 
peroxidation and protein oxidation, and reactive oxygen   
species (ROS)] induced by MA. 
METHODS 
  All animals were treated in accordance with the NIH 
Guide for the care and use of laboratory animals (NIH Pub-
lication No. 85-23, 1985; www.dels.nas.edu/ila). This study 
was performed in accordance with the Institute for Labora-
tory Animal Research (ILAR) guidelines for the care and use 
of laboratory animals. Male C57BL/6J mice (Bio Genomic 
Inc., Charles River Technology, Gapyung-Gun, Gyeonggi-
Do, South Korea) weighing 25 ± 3 g were maintained on a 
12 h:12 h light:dark cycle and fed ad libitum. 
  MA was obtained from Korea Food & Drug Administra-
tion (KFDA) and dissolved in 0.9% sterile saline. Methanol 
extract of GE was obtained from Samsung Herb Medicine, 
Co. (Chunchon, South Korea) and suspended in 0.5 % car-Gastrodia elata Bl and Methamphetamine  Current Neuropharmacology, 2011, Vol. 9, No. 1    119 
boxymethylcellulose. All solutions were immediately pre-
pared before use. Experimental schedules in detail are shown 
in Fig. (1A).  
  Locomotor activity and rota-rod performance were   
measured as described previously [13]. Striatal dopamine, 
3,4-dihydroxyphenylacetic acid (DOPAC), homovanilic   
acid (HVA), and TH activity were measured by HPLC-
electrochemical detection [13, 14]. Dopamine turnover rate 
was calculated by the ratio of [(DOPAC + HVA)/ dopa-
mine]. TH expression in the striatum was examined by west-
ern blot or immunocytochemical analyses [13] using primary 
antibody against TH (1:5,000, Chemicon, Temecula, MA, 
USA) or -actin (1:50,000, Sigma-Aldrich, St Louis, MO, 
USA). Protein oxidation was measured by slot blot analysis 
[13] using Oxyblot kit (Chemicon, Temecula, MA, USA) or 
by spectrophotometrical determination using 2,4-dinitro- 
phenylhydrazine (DNPH)-labeling procedure [13]. Lipid 
peroxidation was determined by slot blot analysis using   
primary antibody against 4-hydroxy-2-nonenal (4-HNE) 
(Calbiochem, Gibbstown, NJ, USA) [13] or by HPLC-
UV/VIS detection of malondialdehyde [13]. Synaptosomal 
reactive oxygen species (ROS) was measured as described 
previously [15]. Striatal synaptosomes from four animals 
pooled for each assay. Statistical analyses were performed 
using one-way analysis of variance (ANOVA) or repeated 
measure one-way ANOVA. A post-hoc Fisher’s PLSD test 
was then applied. A p value < 0.05 was deemed to indicate 
statistical significance. 
RESULTS AND DISCUSSION 
  Experimental protocol for this study was shown in Fig. 
(1A). Mice receiving GE (500 or 1000 mg/kg, p.o.) alone did 
not show any specific behaviours. Three days after final MA 
treatment, mice showed significant decreased locomotor 
activity (p < 0.01 vs. Saline) and rota rod performance (p < 
0.01 vs. Saline) (Fig. 1B and C). Representative locomotor 
tracing patterns also support respective locomotor activity 
(Fig.  1B).  GE treatment attenuated these behavioural im-
pairments (Locomotor activity and Rota rod performance; 
Saline + MA vs. GE 500 or 1000 mg/kg + MA, p < 0.05) 
(Fig. 1B and C). 
  MA treatment significantly decreased dopamine levels (p 
< 0.01 vs. Saline), while dopamine turnover rate was signifi-
cantly increased (p < 0.01 vs. Saline). GE treatment signifi-
cantly attenuated changes in dopamine levels (Saline + MA 
vs. GE 500 or 1000 mg/kg + MA, p < 0.05) and dopamine 
turnover rate (Saline + MA vs. GE 500 mg/kg + MA or GE 
1000mg/kg + MA, p < 0.05) and induced by MA (Fig. 2A 
and B).  
  In this study, changes in tyrosine hydroxylase (TH) activ-
ity are in line with those in TH expression (as shown by im-
munocytochemistry and western blot analysis). Consistently, 
tendency of TH activity and TH expressions apparently is in 
line with that of dopamine levels (Fig. 2C and D).  
 Fig.  (3). showed the changes in the lipid peroxidation (as 
shown by 4-HNE expression and MDA level), protein oxida-
tion (as shown by protein carbonyl expression and protein 
carbonyl level) and ROS. A mild expression of 4-HNE   
was observed in saline- or GE-treatment. MA significantly 
increased 4-HNE expression (p < 0.01 vs. Saline). The result 
in 4-HNE expression was consistent with that in MDA level. 
A mild to moderate expression of protein carbonyl was noted 
in the saline or GE-treated group. Similar to 4-HNE, MA 
treatment significantly increased (p < 0.01 vs. Saline) protein 
carbonyl expression and its level. In addition, formations of 
ROS are apparently in line with those of MDA and protein 
carbonyl. GE treatment was significantly inhibited these 
markers of oxidative stress [expressions of HNE and protein 
carbonyl, and formations of MDA, protein carbonyl and 
ROS: Sal + MA vs. GE (500 mg/kg or 1000 mg/kg) + MA, p 
< 0.05]. 
  In the present study, we showed that GE significantly 
attenuates MA-induced impairments in the behavioural   
activity, dopaminergic function, and that GE significantly 
inhibited MA-induced pathologic oxidative changes. There-
fore, our results indicate that GE-mediated antioxidant   
effects may contribute to block MA-induced dopaminergic 
toxicity in mice. To our knowledge, this is the first time that 
GE attenuates dopaminergic toxicity.  
 
 
 
 
 
 
 
 
 
 
 
 
Fig. (1). Experimental schedule for evaluating the effects of Gas-
trodia elata Bl (GE) on methamphetamine (MA)-induced dopaminer-
gic toxicity (A), and effects of GE on the MA-induced behavioural 
impairments [locomotor activity (B) and rota rod performance (C)]. 
Note MA-induced behavioural impairment as shown by representa-
tive locomotor tracing patterns (RLTP). GE significantly attenuates 
this impairment. Mice received GE (500 or 1000 mg/kg, p.o.) twice a 
day for consecutive 6 days. Mice received first MA 90 min after final 
GE. Mice received four times of MA (7.5 mg/kg. i.p.) by 2 hours’ 
time schedule. Mice were sacrificed 3 days after final MA treatment 
to examine biochemical parameters. Each value is the mean ± S.E.M. 
of 10 animals. *p < 0.01 vs. Saline, 
#p < 0.05 vs. Saline + MA (One-
way ANOVA followed by Fischer’s PLSD test). 
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  Major components of GE are vanillyl alcohol, phenolic 
compounds, organic acids, glucose, beta-sitosterol, hydroxy-
benzyl alcohol, vanillin, gastrodin and hydroxybenzaldehyde 
[16]. Vanillyl alcohol showed antioxidant effects in response 
to excitotoxic condition in rats [17]. Gastrodin was reported 
to increase the GABA level by inhibiting the GABA shunt 
[18]. Recently, it was suggested that the order of antioxidant 
potency of components of GE is hydroxylbenzyl alcohol > 
vanillyl alcohol > vanillin > hydroxybenzaldehyde [3]. Cor-
respondingly, Liu and Mori [19] demonstrated that GE inhib-
its cerebral lipid peroxidation via in part modulating antioxi-
dant enzymes. 
  Many evidence indicated that GE mainly modulates 
GABAergic system, although GE also modulates dopa-
minergic and serotonergic systems. Earlier study demon-
strated that high-dose MA enhances dopamine D1 receptor-
mediated nigrostriatal GABAergic transmission, which acti-
vates GABAA receptors in the substantia nigra, leading to a 
decrease in GABAergic nigrothalamic activity, and increase 
in corticostriatal glutamate release, and a consequent long-
term depeletion of striatal dopamine contents [20]. This find-
ing may be associated with increased formation of free radi-
cal [7]. This increase in free radical formation consequently 
results in increases in markers of lipid peroxidation and pro-
tein oxidation, namely MDA/4HNE and protein carbonyl as 
shown in this study. Thus, we raise the possibility that 
GABAergic effects of GE may be, at least in part, important 
for GE-mediated neuroprotection. We observed in our pilot 
study that anti-dopaminergic effects of GE are more pro-
nounced than those of respective component of GE and the 
dose less than 500 mg/kg GE is not effective in preventing 
MA toxicity (data not shown). In addition, it remains to be 
fully determined on the interaction between GABAergic, 
dopaminergic populations and antioxidant components after 
exposed to GE. Combined, we indicate that antioxidant 
properties of GE may be helpful for treatment of oxidative 
stress responsible neurological disorders, although it’s   
precise mechanism remains elusive. 
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